AgelessRx Sermorelin Review 2026: Pricing, Pharmacy & Pros

Pros & Cons

Overview

AgelessRx^[1] is a longevity telehealth platform founded in 2019 in Ann Arbor, Michigan. Its catalog extends well beyond the GH axis into metformin, low-dose naltrexone, rapamycin, and NAD+ protocols, with sermorelin positioned as one entry in a broader longevity formulary rather than the platform's single focus.

Sermorelin is offered in two delivery forms. The subcutaneous injection starts at $99 per month^[1] and the intranasal spray at 1000 mcg/mL starts at $199 per month^[2]. The nasal formulation is the distinguishing feature. No other provider in this comparison publishes a documented intranasal sermorelin product, and it addresses the single most common adherence barrier in GH axis therapy: patients who will not commit to nightly subcutaneous injection.

The intake is asynchronous. Patients complete a health questionnaire, and a US-licensed prescriber^[3] reviews it without a live video visit. The prescriber issues a tailored titration schedule and dosing instructions^[1], and the shipment includes enough needles and syringes to complete the monthly schedule. There is no membership fee and no separate consultation charge layered on top of the medication cost.

AgelessRx applies an age floor that most competitors do not. Patients under 30 are directed to other longevity options^[1] rather than prescribed sermorelin. Intake screening also excludes patients with active cancer history, untreated hypothyroidism, hyperglycemia or diabetes, liver or kidney disease, and pregnancy. This is a more conservative eligibility standard than the age-agnostic wellness framing used by several platforms in this comparison.

Pharmacy and Compound Quality

AgelessRx states that all partner pharmacies are certified 503A compounding pharmacies^[3] subject to FDA compliance requirements including regular facility and product inspections. 503A pharmacies compound for individually identified patients^[5] under state board oversight. They are not held to the current Good Manufacturing Practice standards that govern 503B outsourcing facilities^[6], which is the higher regulatory tier.

This is a meaningful distinction when comparing AgelessRx against providers that source from 503B facilities. A 503A-only supply chain is standard and legal for patient-specific compounded sermorelin, but it means batch-level release testing is governed by USP 797 sterility^[7] requirements applied at the state level rather than by federal cGMP inspection. AgelessRx does not publish per-lot potency or endotoxin testing results the way some competitors do.

The company carries the standard compounded-medication disclosure that the FDA has not approved or reviewed sermorelin for safety, efficacy, or quality for any use^[1], including its own compounded product. This is accurate and applies equally to every compounded sermorelin product in this comparison. Sermorelin was withdrawn from the US market as an approved finished drug in 2008 and is available only through compounding.

Protocol and Dosing

The injectable protocol follows standard practice. Sermorelin is administered subcutaneously into fatty tissue such as the thigh or abdomen, at night on an empty stomach at least 2 hours after eating^[1]. Bedtime administration on an empty stomach is the correct clinical approach. Roughly 70 percent of daily GH release occurs during slow-wave sleep, and elevated blood glucose blunts the GH pulse through somatostatin feedback.

The prescriber sets an individualized titration schedule rather than a fixed dose. Standard starting doses for compounded sermorelin fall in the 100 to 300 mcg per day range, with titration based on symptom response. AgelessRx does not publish its dose ladder publicly, so patients should confirm the target range and escalation timeline during intake.

The intranasal spray at 1000 mcg/mL^[2] uses a different absorption route. Intranasal peptide delivery bypasses subcutaneous injection but has lower and more variable bioavailability than the subcutaneous route. Patients should treat the nasal form as a distinct protocol rather than a milligram-for-milligram substitute for the injection, and should not assume equivalent IGF-1 response at the same nominal dose.

Patients can cancel or pause a subscription at any time prior to the next shipment^[3] with a minimum of 48 hours notice. There is no minimum term commitment, which distinguishes AgelessRx from providers whose lowest advertised price requires a 3-month or 6-month prepayment.

What to Expect

Who Qualifies and What Intake Involves

Eligibility starts with an age floor: AgelessRx prescribes sermorelin only to patients 30 and older^[1]. Screening excludes untreated hypothyroidism, hyperglycemia and diabetes, liver or kidney disease, active or prior cancer, and pregnancy. Thyroid status matters clinically because untreated hypothyroidism blunts the GH response and will make a sermorelin protocol look like a failure when the actual problem is upstream.

The intake does not require baseline IGF-1^[4] testing, and lab work is not included in the program price. This is the clearest weakness in the AgelessRx offering measured against the criteria used throughout this site. IGF-1 is the primary marker for evaluating GH axis function and dose response. Without a pre-treatment value, a 90-day retest has nothing to compare against, and dose titration reduces to symptom report.

Patients who choose AgelessRx should arrange an independent baseline IGF-1 draw before the first injection, and repeat it at 90 days. Direct-to-consumer lab panels covering IGF-1 typically run $60 to $120, which still leaves the all-in first-year cost competitive against providers that bundle labs at a higher monthly rate.

AgelessRx states it services every US state^[3], though it notes that cold-shipped injectables cannot be reliably shipped to noncontiguous states. Patients in Alaska and Hawaii should confirm injectable availability before enrolling, or consider the nasal formulation, which does not carry the same cold-chain constraint.

What Stands Out

The intranasal formulation^[2] is a genuine differentiator, not a marketing variant. Injection avoidance is a documented reason patients decline or abandon GH axis therapy, and AgelessRx is the only provider here with a published nasal product. Patients should go in understanding that intranasal bioavailability is lower and more variable than subcutaneous delivery, which is part of why the nasal form is priced higher for what is nominally the same peptide.

The $99 entry price is the second lowest in this comparison and carries no membership fee, no consultation charge, and no minimum term. For a patient who already has recent labs and wants to start quickly, the economics are strong.

Two cautions belong in the same frame. AgelessRx is not BBB accredited and carries a D- rating, which the Better Business Bureau attributes to the company failing to respond to two complaints^[8]. That is a responsiveness mark on a small complaint volume rather than evidence of a systemic problem, and it sits alongside a 4.4 out of 5 Trustpilot rating across a much larger review base^[9]. Read the two together rather than either alone.

The second caution is structural. The asynchronous-only model means there is no live consultation with the prescriber at any point. Patients who want to talk through dose strategy in conversation rather than through a messaging portal will find the format limiting, particularly during the first 90 days when titration decisions are being made.

What's Included

• Sermorelin injection from $99/month, intranasal spray from $199/month at 1000 mcg/mL
• Asynchronous physician review with no video visit required
• Dispensed through 503A compounding pharmacies, available in all 50 states

How It Works

Pricing

Customer Support

Bottom Line

Frequently Asked Questions